Tissue penetration of antimicrobials: Difference between revisions

From IDWiki
Line 13: Line 13:
| rowspan="3" |[[Penicillins]]
| rowspan="3" |[[Penicillins]]
|Ξ²-lactamase inhibitors
|Ξ²-lactamase inhibitors
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
|-
|-
|[[ampicillin]]
|[[ampicillin]]
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
|-
|-
|[[piperacillin-tazobactam]]
|[[piperacillin-tazobactam]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +†
| +†
| style="text-align:center" |
|
|-
|-
| rowspan="5" |[[Cephalosporins]]
| rowspan="5" |[[Cephalosporins]]
|first-generation cephalosporins
|first-generation cephalosporins
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
|-
|-
|second-generation cephalosporins
|second-generation cephalosporins
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
|-
|-
|third-generation cephalosporins
|third-generation cephalosporins
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +†
| +†
| style="text-align:center" |
|
|-
|-
|[[cefepime]]
|[[cefepime]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
|-
|-
|[[ceftazidime]]
|[[ceftazidime]]
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
|-
|-
| rowspan="2" |[[Cephamycins]]
| rowspan="2" |[[Cephamycins]]
|[[cephamycins]]
|[[cephamycins]]
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
|-
|-
|[[cefoxitin]]
|[[cefoxitin]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
|-
|-
|[[Carbapenems]]
|[[Carbapenems]]
|[[imipenem]]
|[[imipenem]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
|-
|-
Line 95: Line 95:
|-
|-
|[[Aminoglycosides]]
|[[Aminoglycosides]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
|-
|-
|[[Chloramphenicol]]
|[[Chloramphenicol]]
|[[chloramphenicol]]
|[[chloramphenicol]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
|-
|-
|[[Fluoroquinolones]]
|[[Fluoroquinolones]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |–?
| style="text-align:center" |–?
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
| style="text-align:center" | +
| style="text-align:center" | +
Line 120: Line 120:
|[[Fosfomycin]]
|[[Fosfomycin]]
|[[fosfomycin]]
|[[fosfomycin]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| +
| style="text-align:center" |
|
|-
|-
|[[Lincosamides]]
|[[Lincosamides]]
|[[clindamycin]]
|[[clindamycin]]
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
|-
|-
|[[Macrolides]]
|[[Macrolides]]
|[[macrolides]]
|[[macrolides]]
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
| style="text-align:center" |
|
|-
|-
|[[Nitrofurans]]
|[[Nitrofurans]]
Line 152: Line 152:
|[[Nitroimidazoles]]
|[[Nitroimidazoles]]
|[[metronidazole]]
|[[metronidazole]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
|-
|-
|[[Rifamycins]]
|[[Rifamycins]]
|[[rifampin]]
|[[rifampin]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
| style="text-align:center" |
|
|-
|-
|[[Sulfonamides]]
|[[Sulfonamides]]
|[[trimethoprim-sulfamethoxazole]]
|[[trimethoprim-sulfamethoxazole]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
| style="text-align:center" |
|
|-
|-
| rowspan="2" |[[Tetracyclines]]
| rowspan="2" |[[Tetracyclines]]
|[[tetracyclines]]
|[[tetracyclines]]
| style="text-align:center" |
|
| style="text-align:center" |–
| style="text-align:center" |–
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
| style="text-align:center" |
|
|-
|-
|[[doxycycline]]
|[[doxycycline]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| +
| style="text-align:center" | +
| style="text-align:center" | +
|-
|-
Line 193: Line 193:
|[[Azoles]]
|[[Azoles]]
|[[fluconazole]]
|[[fluconazole]]
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" |
|
| style="text-align:center" | +
| style="text-align:center" | +
|-
|-
|[[Echinocandins]]
|[[Echinocandins]]
| style="text-align:center" |
|
| style="text-align:center" | +
| +
| style="text-align:center" |
|
| style="text-align:center" |–
|–
| style="text-align:center" |
|
| style="text-align:center" |
|
|-
|-
!Class
!Class

Revision as of 18:50, 16 September 2020

Summary

Class Antimicrobial Blood CNS Urine Prostate Necrotic
Antibiotics: Ξ²-Lactams
Penicillins Ξ²-lactamase inhibitors –
ampicillin + –
piperacillin-tazobactam +†
Cephalosporins first-generation cephalosporins – –
second-generation cephalosporins –
third-generation cephalosporins +†
cefepime +
ceftazidime + +
Cephamycins cephamycins –
cefoxitin –
Carbapenems imipenem +
Antibiotics: Non-Ξ²-Lactams
Aminoglycosides –
Chloramphenicol chloramphenicol +
Fluoroquinolones –? + +
Fosfomycin fosfomycin +
Lincosamides clindamycin – +
Macrolides macrolides – +
Nitrofurans nitrofurantoin – – + – –
Nitroimidazoles metronidazole +
Rifamycins rifampin +
Sulfonamides trimethoprim-sulfamethoxazole +
Tetracyclines tetracyclines – +
doxycycline + +
Antifungals
Azoles fluconazole +
Echinocandins + –
Class Antimicrobial Blood CNS Urine Prostate Necrotic
  • † if inflammation present

Prostate

  • Poorly penetrated by most antibiotics
  • Penetration is higher with a high concentration gradient, high lipid solubility, low degree of ionization, high dissociation constant, low protein binding, and small molecular size
  • Fluoroquinolones are the mainstay of therapy, though there is increasing resistance
  • TMP-SMX often used, though conflicting data about its penetration into the prostate
  • Minocycline, doxycycline, and macrolides achieve high levels in the prostate but are rarely indicated for the causative organisms
  • Third-generation cephalosporins and carbapenems can be used
  • Piperacillin, aztreonam, imipenem, and some aminoglycosides are likely useful

References

  1. ^  Cornelia B. Landersdorfer, JΓΌrgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe, Fritz SΓΆrgel. Penetration of Antibacterials into Bone. Clinical Pharmacokinetics. 2009;48(2):89-124. doi:10.2165/00003088-200948020-00002.
  2. a b c d e f g h i j k l m n o p q r  L. Brockhaus, D. Goldblum, L. Eggenschwiler, S. Zimmerli, C. Marzolini. Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clinical Microbiology and Infection. 2019;25(11):1364-1369. doi:10.1016/j.cmi.2019.01.017.
  3. a b  Takashi Suzuki, Toshihiko Uno, Guangming Chen, Yuichi Ohashi. Ocular distribution of intravenously administered micafungin in rabbits. Journal of Infection and Chemotherapy. 2008;14(3):204-207. doi:10.1007/s10156-008-0612-5.
  4. a b c d e f g h  Timothy Felton, Peter F. Troke, William W. Hope. Tissue Penetration of Antifungal Agents. Clinical Microbiology Reviews. 2014;27(1):68-88. doi:10.1128/cmr.00046-13.